Feb. 6, 2020: HIV medication costs outpace inflation; HIV's role in attenuating childhood vaccinations; the challenges of researching effects of medications during pregnancy; the need for localized HIV interventions in the U.S.
Advocates say the price is a step in the right direction. But does it go far enough?
The Well Project provides a rundown of their own presentations at the International AIDS Conference as well as highlights from other presenters.
Questions and answers on potential risk of neural tube defects in infants born to women who were taking dolutegravir (DTG) at the time of conception.
Brand Name: Tivicay Other Names: DTG, dolutegravir sodium Drug Class: Integrase Inhibitors
Tivicay is a mainstay of HIV treatment and the focus of simplified treatment studies due to its power and high drug resistance barrier; however, side effects concerns have recently been raised.
Table of Contents
What Is Dolutegravir? Who Should Take It? What Is Drug Resistance? How Is Dolutegravir Taken? What Are the Side Effects? How Does It React With Other Drugs? The Bottom Line
What Is Dolutegravir?
Stribild, a once-daily, single-pill regimen, and Tivicay, a recently approved integrase inhibitor, are now officially on the list of "preferred" HIV medications in official U.S. HIV treatment guidelines.